AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

BACKGROUND: Binding and neutralising anti-Spike antibodies play a key role in immune defence against SARS-CoV-2 infection. Since it is known that antibodies wane with time and new immune-evasive variants are emerging, we aimed to assess the dynamics of anti-Spike antibodies in an African adult popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Chibwana, Marah G., Moyo-Gwete, Thandeka, Kwatra, Gaurav, Mandolo, Jonathan, Hermanaus, Tandile, Motlou, Thopisang, Mzindle, Nonkululeko, Ayres, Frances, Chaponda, Mphatso, Tembo, Godwin, Mwenechanya, Percy, Mitole, Ndaona, Jassi, Chisomo, Kamng’ona, Raphael, Afran, Louise, Mzinza, David, Mwandumba, Henry C., Gordon, Stephen B., Jere, Khuzwayo, Madhi, Shabir, Moore, Penny L., Heyderman, Robert S., Jambo, Kondwani C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958481/
https://www.ncbi.nlm.nih.gov/pubmed/35346184
http://dx.doi.org/10.1186/s12916-022-02342-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958481/
https://www.ncbi.nlm.nih.gov/pubmed/35346184
http://dx.doi.org/10.1186/s12916-022-02342-z

Ejemplares similares